Incidence of chronic disorders,
especially among the geriatric population, has highly increased in the last few
years, when the count of patients treated in emergency units such as NICUs and
ICUs has also experienced a steep leap, which in turn has boosted the global blood
gas and electrolyte analyzers market significantly. At the same time, rise in
product approvals by the respective bodies and increase in healthcare expenditure across the world have supplemented the market
growth yet more.
Moreover, the smart assimilation of
blood gas analyzers with laboratory information solutions and electronic
medical archives has paved the way for an array of opportunities in the
industry, since these advanced integrated systems not only give way to precise
monitoring of patients' health, but also makes sure that the workflow is
streamlined in the perfect manner.
According to Allied
Market Research, the global blood gas and electrolyte analyzers market is anticipated to exhibit a
noteworthy CAGR from 2021 to 2030. This is majorly attributed to the ongoing
developments in healthcare sphere. These advancements are paving the way for
new implementation of technologies that help the patients as well as the care
providers in best possible ways. For examples, hospitals have started incorporating
technologies such as Virtual Reality and Augmented Reality that can dole out
real-time simulation of human physique, so as to help them figure out the abnormality
of the patient.
The growth of the global blood gas and electrolyte analyzers
market is attributed to rise in geriatric population, increase in prevalence of
chronic diseases, and surge in development for point of care devices. Moreover,
increase in healthcare expenditure is expected to further drive the market
growth during the forecast years.
The growth of the blood gas and electrolyte analyzers market is
majorly driven due to the rise in prevalence of chronic diseases, rise in
global geriatric population, and increase in awareness for early diagnosis. In
addition, growing number of patients being treated in NICUs, ICUs, and
emergency departments, rapid urbanization, and consumption of unhealthy food
significantly boost the blood gas and electrolyte analyzers market growth.
Advantages such as mobility fuels
the market growth-
With the high-end developments in the
healthcare industry, mobility has turned out to be one of the most important
facilities that every healthcare equipment must have these days. This not only
let devices to be highly operative while they are on the move, but also makes
sure they can be wielded in certain emergency. Such technological advancements
have certainly played aprime role in accelerating the demand for blood gas and
electrolyte devices in more than one way.
Download Report Sample PDF- https://www.alliedmarketresearch.com/request-sample/4608
Impact of COVID-19 Pandemic on the Blood Gas and Electrolyte Analyzers Market:
Here, it’s worth stating that the outbreak of the pandemic gave
way to surge in the number of hospitalizations, which in turn led to
considerable rise in blood gas testing since it
is very much important for COVID-19 patients, especially those who show cues of
respiratory issues. These factors had a favorable impact on the market,
especially during the initial phase. This drift is pretty likely to
persist even after the pandemic is completely over.
Leading market players:
- Instrumentation
Laboratory (A Werfen Company) (U.S.)
- Siemens AG
(Germany)
- Roche
Diagnostics Limited (Switzerland)
- Abbott
Laboratories, Inc. (U.S.)
- Nova
Biomedical (U.S.)
- OPTI Medical
Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.) (U.S.)
- ERBA
Diagnostics Mannheim GmbH (Germany)
- Medica
Corporation (U.S.)
- Alere, Inc. (U.S.)
0 Comments